Finder is committed to editorial independence. While we receive compensation when you click links to partners, they do not influence our content.

How to buy DURECT Corporation (DRRX) stocks in Canada

Learn how to easily invest in DURECT Corporation stocks.

DURECT Corporation is a drug manufacturers-specialty & generic business based in the US. DURECT Corporation stocks (DRRX.US) are listed on the NASDAQ and all prices are listed in US Dollars. Its last market close was $1.5 – a decrease of 12.01% over the previous week. DURECT Corporation employs 79 staff and has a trailing 12-month revenue of around $8.9 million.

How to buy shares in DURECT Corporation

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – DRRX – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.

DURECT Corporation stock price (NASDAQ:DRRX)

Use our graph to track the performance of DRRX stocks over time.

DURECT Corporation shares at a glance

Information last updated 2022-01-19.
Latest market close$0.66
52-week range$0.72 - $2.95
50-day moving average $1.01
200-day moving average $1.37
Wall St. target price$6.00
PE ratio N/A
Dividend yield N/A (0%)
Earnings per share (TTM) $-0.11

Compare online stock trading platforms

Note: The dollar amounts in the table below are in Canadian dollars.

Name Product Finder Rating Stock Trading Fee Account Fee Available Asset Types Offer
FREE TRADES
Wealthsimple Trade
Finder Rating:
★★★★★
3.9 / 5
$0
$0
Stocks, ETFs
Get 2 free stocks when you deposit and trade $150.
Scotia iTRADE
Finder Rating:
★★★★★
3.8 / 5
$4.99 - $9.99
$0
Bonds, Options, Mutual Funds, ETFs, GICs, International Equities
Interactive Brokers
Finder Rating:
★★★★★
4.1 / 5
Min. $1.00, Max. 0.5%
$0
Stocks, Bonds, Options, ETFs, Currencies, Futures
OFFER
CIBC Investor's Edge
Finder Rating:
★★★★★
4 / 5
$4.95 - $6.95
$0 if conditions met, otherwise $100/year
Stocks, Bonds, Options, Mutual Funds, ETFs
Get up to $2,000 cash back. Conditions apply. Offer ends March 1, 2022.
Questrade
Finder Rating:
★★★★★
4.2 / 5
$4.95 - $9.95
$0
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs, International Equities, Precious Metals
Get $50 in free trades when you fund your account with a minimum of $1,000.
Qtrade Direct Investing
Finder Rating:
★★★★★
4.1 / 5
$6.95 - $8.75
$0 if conditions met, otherwise $25/quarter
Stocks, Bonds, Options, Mutual Funds, ETFs, GICs
Get a $50 bonus when you open a new RRSP, TFSA or RESP and start pre-authorized contributions of $200+/month. Valid until March 1, 2022.
loading

Compare up to 4 providers

Online stock trading

Is it a good time to buy DURECT Corporation stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

DURECT Corporation price performance over time

Historical closes compared with the close of $0.6599 from 2022-01-21

1 week (2022-01-13) -13.27%
1 month (2021-12-18) N/A
3 months (2021-10-22) -43.11%
6 months (2021-07-22) -54.49%
1 year (2021-01-22) -70.67%
2 years (2020-01-22) -68.87%
3 years (2019-01-22) 11.85%
5 years (2017-01-20) 1.18

DURECT Corporation financials

Revenue TTM $8.9 million
Gross profit TTM $996,000
Return on assets TTM -26.82%
Return on equity TTM -77.13%
Profit margin -280.12%
Book value $0.28
Market capitalisation $164.1 million

TTM: trailing 12 months

DURECT Corporation share dividends

We're not expecting DURECT Corporation to pay a dividend over the next 12 months.

DURECT Corporation share price volatility

Over the last 12 months, DURECT Corporation's shares have ranged in value from as little as $0.72 up to $2.95. A popular way to gauge a stock's volatility is its "beta".

DRRX.US volatility(beta: 1.15)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while DURECT Corporation's is 1.1546. This would suggest that DURECT Corporation's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

DURECT Corporation overview

DURECT Corporation, a biopharmaceutical company, researches and develops medicines based on its epigenetic regulator and pharmaceutical programs. The company offers ALZET product line that consists of osmotic pumps and accessories used for research in mice, rats, and other laboratory animals. It also develops DUR-928, an endogenous, orally bioavailable small molecule that is in Phase IIb clinical trial to play a regulatory role in lipid homeostasis, inflammation, and cell survival, as well as completed Phase Ib clinical trial to treat patients with nonalcoholic steatohepatitis. In addition, the company offers POSIMIR, a post-surgical pain product to deliver bupivacaine up to days of in adults. It markets and sells its ALZET lines through direct sales force in the United States, as well as through a network of distributors in Japan, Europe, and internationally. The company has strategic collaboration and other agreements with Virginia Commonwealth University Intellectual Property Foundation; Indivior UK Ltd. ; Santen Pharmaceutical Co.

Frequently asked questions

Disclaimer: This information should not be interpreted as an endorsement of futures, stocks, ETFs, CFDs, options or any specific provider, service or offering. It should not be relied upon as investment advice or construed as providing recommendations of any kind. Futures, stocks, ETFs and options trading involves substantial risk of loss and therefore are not appropriate for all investors. Trading CFDs and forex on leverage comes with a higher risk of losing money rapidly. Past performance is not an indication of future results. Consider your own circumstances, and obtain your own advice, before making any trades.

More on investing

More guides on Finder

Go to site